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 General Remarks: 
1H-NMR spectra were recorded at 300 or 400 MHz with CDCl3 as solvent. 
13C-NMR spectra 
were obtained at 75.4 or 100.59 MHz in CDCl3. Chemical shifts were determined relative to the 
residual solvent peaks (CHCl3, δ = 7.26 ppm for hydrogen atoms, δ = 77.0 for carbon atoms). The 
following abbreviations are used to indicate signal multiplicity: s, singlet; d, doublet; t, triplet; q, 
quartet; m, multiplet; bs, broad singlet. Enantiomeric excess determination was performed by capillary 
GC analysis or HPLC analysis using flame ionization detector or UV-detection, respectively (all in 
comparison with racemic products, column and conditions further specified in relevant experimentals). 
Optical rotations were measured in CHCl3 on a polarimeter with a 10 cm cell (c given in g/100 mL). 
Absolute configuration of the products was determined by comparison of optical rotations with those of 
compounds previously published. Thin-layer chromatography (TLC) was performed using commercial 
Kieselgel 60, F254 silica gel plates, and components were visualized with KMnO4 or phosphomolybdic 
acid reagent. Flash chromatography was performed on silica gel. Drying of solutions was performed 
with MgSO4 and concentrations were conducted with a rotary evaporator. 
Taniaphos ligand L1 was prepared according to literature procedures
1 or obtained through a 
donation. The substrates 1a,
2 1b,
3 and 1c
4 were prepared according to literature procedures. Grignard 
reagents were purchased as solutions in Et2O (EtMgBr, MeMgBr, n-PentMgBr) or prepared from the 
corresponding alkyl bromides and magnesium turnings in Et2O following standard procedures. 
Grignard reagents were titrated using s-BuOH and catalytic amounts of 1,10-phenanthroline. Et2O (for 
preparation of Grignard reagents) and THF were distilled from Na/benzophenone and CH2Cl2 was 
                                                 
1 Ireland, T.; Grossheimann, G.; Wieser-Jeunesse, C.; Knochel, P. Angew. Chem. Int. Ed. 1999, 38, 3212. 
2 Kottirsch, G.; Koch, G.; Feifel, R.; Neumann, U. J. Med. Chem. 2002, 45, 2289. 
3 a.) Cerezo, S.; Cortès, J.; Galvan, D.; Lago, E.; Marchi, C.; Molins, E.; Moreno-Mañas, M.; Pleixats, R.; Torrejón, J.; 
Vallribera, A. Eur. J. Org. Chem. 2001, 329; b.) Neustadt, B. R. Tetrahedron Lett. 1994, 35, 379. 
4 a.) Lemieux, R. M.; Devine, P. N.; Mechelke, M. F.; Meyers,  A. I. J. Org. Chem. 1999, 64, 3585; b.) Thurner, A.; Faigl, 
F.; Tőke, L.; Mordini, A.; Valacchi, M.; Reginato, G.; Czira, G. Tetrahedon 2001, 57, 8173; c.) McDonald, W. S.; 
Verbicky, C. A.; Zercher, C. K. J. Org. Chem. 1997, 62, 1215.    S  3
distilled from CaH2. All other solvents were used as purchased. Allylic alkylations were conducted 
under argon atmosphere using standard Schlenk techniques. 
Racemic allylic alkylation products were obtained by reaction of the bromides with the 
corresponding Grignard reagent (5.0 equiv) at -25
oC in CH2Cl2 in the presence of CuCN (100 mol %). 
Other racemic products were obtained through the transformations described, vide infra, on the racemic 
allylic alkylation products. The products 2a, 2c, 2f, 3, 4a, 5a, 5c, 6a, and 10 have been previously 
described (see appropriate references in the following pages). 
 
 
General Procedure for the Preparative Enantioselective Cu-catalysed Allylic Alkylation 
with Methyl Grignard: 
In a Schlenk tube equipped with septum and stirring bar, CuBr·SMe2 (75 μmol, 15.4 mg) and 
ligand  L1 (90 μmol, 61.9 mg) were dissolved in CH2Cl2 (15 mL) and stirred under an argon 
atmosphere at room temperature for 10 min. The mixture was cooled to – 75 
oC and the methyl 
Grignard reagent (9.0 mmol, 3M solution in Et2O, 3.0 mL) was added dropwise. Allylic bromide 1a or 
1b (7.5 mmol) was added dropwise as a solution in 2.5 mL CH2Cl2 at that temperature over 60 min via 
a syringe pump. Once the addition was complete the resulting mixture was further stirred at – 75 
oC for 
24h. The reaction was quenched by addition of MeOH (2.5 mL) and the mixture was allowed to reach 
rt. Subsequently, aqueous NH4Cl solution (1M, 30 mL) and 50 mL Et2O were added, the organic phase 
was separated and the resulting aqueous layer was extracted with Et2O (2x 25 mL). The combined 
organic phases were dried and concentrated to yield a yellow oil which was purified by flash 
chromatography. 
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(−)-(S)-((2-Methylbut-3-enyloxy)methyl)benzene (2a):
5 
Purification by column chromatography (SiO2, 1:99 Et2O/pentane, Rf = 0.35) 
afforded 2a (1.24 g) as a colorless oil. [94% yield, 92% ee, [α]D = − 5.4 (c 1.3, CHCl3); lit.
5 [α]D = − 6 
(c 1.1, CHCl3)]; 
1H-NMR δ 7.32-7.21 (m, 5H), 5.81 (ddd, J = 6.9, 10.4 and 17.3 Hz, 1H), 5.11-5.00 (m, 
2H), 4.53 (s, 2H), 3.35 (ddd, J = 6.7, 9.1 and 23.9 Hz, 2H), 2.54-2.49 (m, 1H), 1.05 (d, J = 6.8 Hz, 3H); 
13C-NMR δ 141.3, 138.6, 128.3, 127.5, 127.4, 114.0, 75.0, 72.9, 37.8, 16.6; MS (EI) m/z 176 (M+, 16), 
175 (6), 92 (11), 91 (100), 65 (6); HRMS Calcd. for C12H16O 176.1201, found 176.1207. Enantiomeric 
excess determined of derivatized product 3. 
 
(−)-(S)-(N-2-Methylbut-3-enyl)(N-t-butoxycarbonyl)   
p-toluenesulfonamide (2b): 
Purification by column chromatography (SiO2, 10:90 Et2O/pentane, Rf = 0.30) 
afforded 2b (2.45 g) as a colorless oil. [96% yield, 95% ee, [α]D = − 7.7 (c 1.4, CHCl3)]; 
1H-NMR 
δ 7.78 (d, J = 8.4 Hz, 2H), 7.29 (d, J = 8.4 Hz, 2H), 5.73 (ddd, J = 8.1, 10.2 and 17.3 Hz, 1H), 5.10-
5.00 (m, 2H), 3.82-3.72 (m, 2H), 2.78-2.66 (m, 1H), 2.43 (s, 3H), 1.32 (s, 9H), 1.07 (d, J = 6.8 Hz, 3H); 
13C-NMR δ 151.0, 144.0, 140.7, 137.5, 129.1, 127.9, 115.3, 84.0, 51.9, 38.7, 27.8, 21.5, 17.3; MS (EI) 
m/z 283 (9), 216 (20), 185 (6), 184 (64), 155 (42), 91 (39), 68 (7), 65 (11), 57 (100), 56 (5), 55 (13); 
MS (CI) m/z 359 (8), 358 (20), 357 ([M+NH4]+,100), 302 (7), 301 (40), 284 (6). HRMS Calcd. for [M-
Me2C=CH2]
+ C13H17NO4S 283.0878, found 283.0887. Enantiomeric excess determined of derivatized 
product 7. The absolute configuration was assigned by comparison of the sign of the optical rotation of 
derivatized product 10 with the literature value. 
 
 
                                                 
5 López, F.; van Zijl, A. W.; Minnaard, A. J.; Feringa. B. L. Chem. Commun. 2006, 409. 
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General Procedure for the Enantioselective Cu-catalysed Allylic Alkylations: 
In a Schlenk tube equipped with septum and stirring bar, CuBr·SMe2 (15 μmol, 3.1 mg) and 
ligand L1 (18 μmol, 12.4 mg) were dissolved in CH2Cl2 (2.5 mL) and stirred under argon at room 
temperature for 10 min. The mixture was cooled to – 75 
oC and the Grignard reagent (0.45 mmol, 
solution in Et2O) was added dropwise. The allylic bromide (0.3 mmol) was then added dropwise as a 
solution in 0.5 mL CH2Cl2 at – 75 
oC over 15 min. Once the addition was complete the resulting 
mixture was further stirred at – 75 
oC. After full conversion was established by TLC the reaction was 
quenched by addition of MeOH (0.5 mL) and the mixture was allowed to reach rt. Then, sat. aqueous 
NH4Cl solution (1.5 mL) was added, the organic phase was separated and the aqueous phase was 
extracted with Et2O (2x 2.5 mL). The combined organic phases were dried and concentrated to yield a 
yellow oil which was purified by flash chromatography. 
 
(−)-(S)-4-[(tert-Butyldiphenylsilyl)oxy]-3-methylbut-1-ene (2c):
6  
Purification by column chromatography (SiO2, 0.2:99.8 Et2O/pentane, Rf = 0.25) 
afforded 2c (70.3 mg) as a colorless oil. [72% yield, 94% ee, [α]D = − 2.7 (c 1.3, 
CHCl3); lit.
6 [α]D = − 3.18 (94% ee, c 0.71, CHCl3)]; 
1H-NMR δ 7.68 (dd, J = 7.7 and 1.6 Hz, 4H), 
7.45-7.36 (m, 6H), 5.81 (ddd, J = 6.9, 10.4 and 17.4Hz, 1H), 5.06-4.98 (m, 2H), 3.58 (dd, J = 9.7 and 
6.2 Hz, 1H), 3.50 (dd, J = 9.7 and 6.7 Hz, 1H), 2.44-2.37 (m, 1H), 1.06 (s, 9H), 1.04 (d, J = 6.8 Hz, 
3H); 
13C-NMR δ 141.3, 135.6, 133.9, 129.5, 127.6, 114.0, 68.5, 40.2, 26.9, 19.3, 16.2; MS (EI) m/z 268 
(24), 267 ([M-tBu]+, 100), 240 (17), 239 (80), 237 (12), 211(9), 199 (15), 197 (14), 190 (7), 189 (36), 
183 (23), 182 (7), 181 (19), 159 (19), 135 (18), 121 (10), 105 (11), 77 (7); MS (CI) m/z 344 (8), 343 
(28), 342 ([M+NH4]+, 100), 325 ([M+H]+, 14). HRMS Calcd. for [M-tBu]
+ C 17H19OSi 267.1205, 
found 267.1197. Enantiomeric excess determined of derivatized product 5a (Scheme S1, page S16).  
                                                 
6 H. Lebel, V. Paquet J. Am. Chem. Soc. 2004, 126, 320. 
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(−)-(N-2-Ethylbut-3-enyl)(N-tert-butoxycarbonyl) 
p-toluenesulfonamide (2e): 
Purification by column chromatography (SiO2, 5:95 Et2O/pentane, Rf = 0.25) 
afforded 2e (87.5 mg) as a colorless oil. [83% yield, 91% ee, [α]D = − 0.4 (c 8.5, CHCl3)]; 
1H-NMR δ 
7.75 (d, J = 8.1Hz, 2H), 7.26 (d, J = 8.1Hz, 2H), 5.59-5.49 (m, 1H), 5.06-5.00 (m, 2H), 3.78 (d, J = 
7.7Hz, 2H), 2.49-2.40 (m, 1H), 2.39 (s, 3H), 1.55-1.44 (m, 1H), 1.29 (s, 9H) ppm 1.26-1.18 (m, 1H), 
0.88 (t, J = 7.4Hz, 3H); 
13C-NMR δ 151.0, 143.9, 139.3, 137.5, 129.0, 127.8, 117.2, 83.9, 50.8, 46.7, 
27.7, 24.8, 21.5, 11.5; MS (EI) m/z 353 (M
+, 0.1), 297 (15), 216 (10), 185 (9), 184 (88), 155 (49), 92 
(5), 91 (39), 82 (39), 69 (7), 65 (9), 57 (100); MS (CI) m/z 373 (9), 372 (20), 371 ([M+NH4]
+, 100), 
317 (6), 316 (12), 315 (75), 298 (8), 271 (8). HRMS Calcd. for [M-Me2C=CH2]
+ C14H19NO4S 
297.1035, found 297.1027. Enantiomeric excess determined of derivatized product 5e. In accordance 
with the results obtained in the other allylic alkylations, the absolute configuration of this compound is 
assumed to be (S), analogous to the other products. 
 
(+)-(S)-((2-n-Butylbut-3-enyloxy)methyl)benzene (2f):
7 
Purification by column chromatography (SiO2, 1:99 Et2O/pentane, Rf = 0.50) 
afforded 2f (60.5 mg) as a colorless oil. [93% yield, 94% ee, [α]D = + 18.5 (c 2.2, CHCl3)]; 
1H-NMR δ 
7.38-7.27 (m, 5H), 5.70 (ddd, J = 8.4, 10.6 and 17.0Hz, 1H), 5.13-5.07 (m, 2H), 4.54 (s, 2H), 3.42 (d, J 
= 6.4Hz, 2H), 2.42-2.32 (m, 1H), 1.60-1.48 (m, 1H), 1.40-1.20 (m, 5H), 0.92 (t, J = 7.0Hz, 3H); 
13C-
NMR δ 140.4, 138.6, 128.3, 127.5, 127.4, 115.4, 73.8, 72.9, 44.1, 30.9, 29.1, 22.8, 14.0; MS (EI) m/z 
218 (M+, 11), 107 (13), 105 (6), 104 (7), 97 (8), 96 (6), 92 (15), 91 (100), 85 (11), 83 (16), 69 (6), 65 
(8), 57 (8), 55 (21); HRMS Calcd. for C15H22O 218.1671, found 218.1665. Enantiomeric excess 
determined by chiral HPLC analysis, Chiralcel OD-H (100% heptane), 40ºC, retention times (min): 
                                                 
7 Yadav, J. S.; Reddy, P. S. Synth. Commun. 1986, 16, 1119. 
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11.6 (minor) and 13.6 (major). The absolute configuration was assigned by comparison of the sign of 
optical rotation of the hydrogenated product 2-ethylhexan-1-ol (Pd/C, H2 in MeOH) with the literature 
value.
8 
 
(+)-(S)-((2-n-Pentylbut-3-enyloxy)methyl)benzene (2g):  
Purification by column chromatography (SiO2, 1:99 Et2O/pentane, Rf = 
0.50) afforded 2g (60.4 mg) as a colorless oil. [87% yield, 94% ee, [α]D = + 14.4 (c 2.4, CHCl3)]; 
1H-
NMR δ 7.38-7.28 (m, 5H), 5.70 (ddd, J = 8.4, 10.6 and 17.0Hz, 1H), 5.14-5.07 (m, 2H), 4.55 (s, 2H), 
3.42 (d, J = 6.5Hz, 2H), 2.42-2.32 (m, 1H), 1.59-1.46 (m, 1H), 1.40-1.21 (m, 7H), 0.91 (t, J = 6.9Hz, 
3H); 
13C-NMR δ 140.4, 138.6, 128.2, 127.5, 127.4, 115.4, 73.8, 72.9, 44.1, 31.9, 31.2, 26.6, 22.6, 14.1; 
LRMS (EI) m/z 232 (M+, 24), 231 (6), 161 (7), 107 (8), 105 (5), 104 (11), 92 (14), 91 (100), 69 (14), 
65 (5), 55 (8); HRMS Calcd. for C16H24O 232.1827, found 232.1835. Enantiomeric excess determined 
by chiral HPLC analysis, Chiralcel OD-H (100% heptane), 40ºC, retention times (min): 11.5 (minor) 
and 13.3 (major). The absolute configuration was assigned by comparison of the sign of optical 
rotation of the hydrogenated product 2-ethylheptan-1-ol (Pd/C, H2 in MeOH) with the literature value.
9  
 
(+)-(S)-(2-Vinyl-hex-5-enyloxymethyl)-benzene (2h): 
Purification by column chromatography (SiO2, 1:99 Et2O/pentane, Rf = 0.50) 
afforded 2h as a colorless oil. [89% yield, 90% ee, [α]D = + 10.0 (c 2.5, CHCl3)]; 
1H-NMR δ 7.40-7.27 
(m, 5H), 5.82 (tdd, J = 6.6, 10.2 and 16.9 Hz, 1H), 5.74-5.64 (m, 1H), 5.14-4.94 (m, 4H), 4.53 (s, 2H), 
3.46-3.38 (m, 2H), 2.45-2.36 (m, 1H), 2.18-1.97 (m, 2H), 1.70-1.60 (m, 1H), 1.44-1.34 (m, 1H); 
13C-
NMR δ 139.9, 138.7, 138.5, 128.3, 127.5, 127.4, 115.8, 114.5, 73.7, 72.9, 43.5, 31.1, 30.4; MS (EI) m/z 
216 (M
+, 0.4), 173 (6), 95 (6), 92 (11), 91 (100), 79 (6), 67 (8), 65 (11), 55 (5); HRMS Calcd. For 
                                                 
8 Larpent, C.; Chasseray, X. Tetrahedron 1992, 48, 3903. 
9 Garcia-Ruiz, V.; Woodward, S. Tetrahedron: Asymm. 2002, 13, 2177. 
O
O   S  8
C15H20O 216.1514, found 216.1513. Enantiomeric excess determined by chiral HPLC analysis, 
Chiralcel OD (100% heptane), 40ºC, retention times (min): 7.5 (minor) and 8.5 (major). The absolute 
configuration was assigned by comparison of the sign of optical rotation of the hydrogenated product 
2-ethylhexan-1-ol (Pd/C, H2 in MeOH) with the literature value.
8  
 
(+)-(2-Vinyl-4-phenyl-butyloxymethyl)-benzene (2i): 
Purification by column chromatography (SiO2, 1:99 Et2O/pentane, Rf = 
0.50) afforded 2i (69.0 mg) as a colorless oil. [86% yield, 92% ee, [α]D = + 3.8 (c 2.2, CHCl3)]; 
1H-
NMR δ 7.42-7.35 (m, 4H), 7.35-7.29 (m, 3H), 7.25-7.20 (m, 3H), 5.78 (ddd, J = 8.5, 11.0 and 16.5Hz, 
1H), 5.21-5.15 (m, 2H), 4.55 (s, 2H), 3.51-3.43 (m, 2H), 2.78-2.69 (m, 1H), 2.59 (ddd, J = 6.6, 10.2 
and 13.8Hz, 1H), 2.51-2.41 (m, 1H), 1.93 (dddd, J = 4.6, 6.6, 11.1 and 13.4Hz, 1H), 1.70-1.60 (m, 1H); 
13C-NMR δ  142.4, 139.8, 138.5, 128.4, 128.3, 128.2, 127.5, 127.4, 125.6, 116.1, 73.7, 72.9, 43.7, 33.2, 
33.0; MS (EI) m/z 266 (M
+, 3), 162 (5), 157 (10), 129 (6), 104 (5), 92 (10), 91 (100), 65 (10); HRMS 
Calcd. for C19H22O 266.1671, found 266.1682. Enantiomeric excess determined by chiral HPLC 
analysis, Chiralcel OD (99.5% heptane/i-PrOH), 40ºC, retention times (min): 8.1 (minor) and 10.0 
(major). In accordance with the results obtained in the other allylic alkylations, the absolute 
configuration of this compound is assumed to be (S), analogous to the other products. 
 
(+)-(S)-4-Benzyloxy-3-methylbutan-1-ol (3):
10 
To a cooled solution (0°C) of 2a (0.5 mmol, 88 mg) in THF (3.5 mL) a 
solution of 9-BBN (0.75 mmol, 0.5M in THF, 1.5 mL) was added. The reaction mixture was stirred for 
3h, then it was allowed to reach rt, after which sequentially  EtOH (2.5 mL), aq. NaOH (1M, 2.5 mL) 
and aq. H2O2 (30%, 2.0 mL) were added. The resulting mixture was stirred vigorously overnight at rt, 
                                                 
10 Smith, A. B., III; Adams, C. M.; Kozmin, S. A.; Paone, D. V. J. Am. Chem. Soc. 2001, 123, 5925. 
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then quenched with aq. Na2S2O3 (10%, 10 mL). CH2Cl2 (20 mL) was added, the organic phase was 
separated and the aqueous phase was extracted with CH2Cl2 (20 mL). The combined organic layers 
were dried and concentrated in vacuo. Purification by column chromatography (SiO2, 40:60 
Et2O/pentane, Rf = 0.25) afforded 3 (77.3 mg) as a colorless oil. [80% yield, 92% ee, [α]D = + 1.8 (c 
2.9, EtOH), − 5.5 (c 2.7, CHCl3), lit.
11 [α]D = + 2.2 (c 1.1, EtOH), + 6.26 (c 5.5, CHCl3)
11c]; 
1H-NMR δ 
7.39-7.26 (m, 5H), 4.52 (s, 2H), 3.75-3.61 (m, 2H), 3.35 (ddd, J = 6.2, 9.1 and 16.5Hz, 2H), 2.42 (bs, 
1H), 1.95 (tq, J = 6.9 and 13.8Hz, 1H), 1.69-1.51 (m, 2H), 0.95 (d, J = 6.9Hz, 3H);
 13C-NMR δ 138.0, 
128.4, 127.7, 76.1, 73.2, 61.2, 38.1, 31.4, 17.7; MS (EI) m/z 194 (M+, 7), 108 (11), 107 (37), 105 (6), 
92 (28), 91 (100), 85 (12), 79 (7), 77 (8), 65 (15), 55 (8); HRMS Calcd. for C12H18O2 194.1307, found 
194.1309. Enantiomeric excess determined by chiral HPLC analysis, Chiralcel OD-H (99% heptane/i-
PrOH), 40ºC, retention times (min): 57.7 (major) and 64.9 (minor). 
 
(−)-(R)-4-Benzyloxy-3-methylbutan-2-one (4a):
12 
A suspension of PdCl2 (50 μmol, 8.9 mg) and CuCl (1.0 mmol, 99 mg) in 
DMF/H2O (6:1, 5 mL) was stirred vigorously under an O2-stream for 1.5h at rt. After addition of 2a 
(0.5 mmol, 88 mg) vigorous stirring was continued for 32h under an O2-atmosphere at rt. Then, H2O 
(20 mL) was added and the mixture was extracted with Et2O/pentane (1:1, 10 mL, 3x).  The combined 
organic layers were washed with H2O (10 mL), dried and concentrated in vacuo. Purification by flash 
column chromatography (SiO2, 10:90 Et2O/pentane, Rf = 0.20) afforded 4a (82.4 mg) as a colorless oil. 
[86% yield, 92% ee, [α]D = − 14.0 (c 4.0, CHCl3), lit.
12b [α]D = − 16.7 (c 3.91, CHCl3)]; 
1H-NMR δ  
7.37-7.26 (m, 5H), 4.50 (d, J = 1.8Hz, 2H), 3.63 (dd, J = 7.5 and 9.2Hz, 1H), 3.49 (dd, J = 5.5 and 
                                                 
11 a.) Fuganti, C.; Grasselli, P. J. Chem. Soc. Chem. Commun. 1979, 995; b.) Schmid, R.; Hansen, H.-J. Helv. Chim. Acta 
1990, 73, 1258; c.) The optical rotation in CHCl3 is reported only once, but appears to be given in the wrong sign: Schmid, 
R.; Antoulas, S.; Rüttimann, A.; Schmid, M.; Vecchi, M.; Weiser, H. Helv. Chim. Acta 1990, 73, 1276. 
12 a.) Myers, A. G.; Yang, B. H.; Chen, H.; McKinstry, L.; Kopecky, D. J.; Gleason, J. L.  J. Am. Chem. Soc. 1997, 119, 
6496; b.) McGuirk, P. R.; Collum, D. B. J. Org. Chem. 1984, 49, 843. 
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9.2Hz, 1H), 2.91-2.81 (m, 1H), 2.18 (s, 3H), 1.10 (d, J = 7.1Hz, 3H); 
13C-NMR δ 211.1, 138.0, 128.4, 
127.6, 127.6, 73.2, 72.1, 47.2, 29.0, 13.4; MS (EI) m/z 192 (M+, 4), 134 (27), 108 (18), 107 (46), 105 
(12), 92 (14), 91 (100), 86 (43), 85 (6), 79 (8), 77 (7), 71 (27), 65 (9); HRMS Calcd. for C12H16O2 
192.1150, found 192.1144. Enantiomeric excess determined by chiral HPLC analysis, Chiralcel AS 
(99.5% heptane/i-PrOH), 40ºC, retention times (min): 11.8 (minor) and 16.4 (major). 
 
(−)-(S)-3-Benzyloxy-2-methylpropan-1-ol (5a):
13 
Ozone was bubbled for 10 min through a solution of 2a (0.5 mmol) in 
CH2Cl2/MeOH (1:1,15mL) cooled to -78°C. NaBH4 (2.5 eq., 2.5 mmol, 95 mg) was added at -78°C 
after which the cooling bath was removed and the reaction mixture was stirred at rt for 2 h.  The 
reaction was quenched by addition of aq. HCl (1M, 15 mL). The organic layer was separated and the 
resulting aqueous layer extracted with CH2Cl2 (25 mL, 2x) the combined organic layers were dried 
(MgSO4) and concentrated in vacuo. Purification by flash column chromatography (SiO2, 30:70 
Et2O/pentane, Rf = 0.30) afforded 5a (47.0 mg) as a colorless oil. [52% yield, 92% ee, [α]D = − 13.0 (c 
2.3, CHCl3), lit.
13 [α]D = − 15.5 (c 1.8, CHCl3)]; 
1H-NMR δ  7.39-7.26 (m, 5H), 4.52 (s, 2H), 3.66-3.53 
(m, 3H), 3.43 (dd, J = 8.0 and 9.0Hz, 1H), 2.56 (bs, 1H), 2.14-2.02 (m, 1H), 0.89 (d, J = 7.0Hz, 
3H); 
13C-NMR δ 138.0, 128.4, 127.6, 127.5, 75.1, 73.3, 67.5, 35.5, 13.4; LRMS (EI) m/z 180 (M
+, 10), 
108 (13), 107 (51), 105 (6), 92 (23), 91 (100), 89 (5), 79 (15), 78 (5), 77 (13), 65 (18), 51 (7); HRMS 
Calcd. for C11H16O2 180.1150, found 180.1157. Enantiomeric excess determined by chiral HPLC 
analysis, Chiralcel AS (98.5% heptane/i-PrOH), 40ºC, retention times (min): 11.9 (minor) and 14.0 
(major). 
 
                                                 
13 Paquette, L. A.; Guevel, R.; Sakamoto, S.; Kim, I. H.; Crawford, J. J. Org. Chem. 2003, 68, 6096. 
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(−)-(R)-3-Benzyloxy-2-methylpropionic acid (6a):  
To a biphasic system of 2a (0.5 mmol) and NaIO4 (2.05 mmol, 438 mg) in 
CCl4/MeCN/H2O (1:1:1.5, 5 mL), RuCl3·xH2O (25 μmol, 5.2 mg) was added and the reaction was 
stirred vigorously overnight. Afterwards, 10 mL CH2Cl2 and 5 mL H2O were added and the organic 
layer was separated, the aqueous layer was further extracted with CH2Cl2 (3x 5mL) and the combined 
organic layers were dried (MgSO4) and concentrated in vacuo. The residue was dissolved in Et2O (10 
mL) and extracted with sat. aq. NaHCO3 (3x 5 mL), the combined aqueous layers were acidified and 
extracted with CH2Cl2 (3x 10 mL). Drying (MgSO4) and concentrating the combined CH2Cl2 layers in 
vacuo afforded 6a (50.3 mg) as a colorless oil. [52% yield, 92% ee, [α]D = − 6.7 (c 2.7, CHCl3), lit.
12b 
[α]D = − 8.5 (c 3.7, CHCl3)]; 
1H-NMR δ 10.78 (bs, 1H), 7.40-7.27 (m, 5H), 4.56 (s, 2H), 3.66 (dd, J = 
7.5 and 9.0Hz, 1H), 3.55 (dd, J = 5.7 and 9.1Hz, 1H), 2.88-2.78 (m, 1H), 1.22 (d, J = 7.1Hz, 3H); 
13C-
NMR δ  180.8, 137.8, 128.3, 127.6, 127.6, 73.1, 71.5, 40.1, 13.7; MS (EI) m/z 194 (M
+, 16), 108 (9), 
107 (83), 105 (8), 92 (13), 91 (100), 89 (5), 79 (23), 77 (14), 73 (6), 65 (18), 51 (7); HRMS Calcd. for 
C11H14O3 194.0943, found 194.0948. Enantiomeric excess determined by chiral GC analysis, CP-
Chiralsil-Dex-CB (25 m x 0.25 mm), isothermic 150 ºC, retention times (min): 41.5 (minor) and 42.9 
(major). 
 
 (−)-(S)-(N-tert-Butoxycarbonyl)(2-methylbut-3-enyl)amine (7): 
To a solution of 2b (0.5 mmol, 170 mg) in MeOH (6 mL) Mg-powder (2.5 
mmol, 61 mg) was added and the mixture was sonicated for 60 min at rt. The resulting suspension was 
diluted with CH2Cl2 (20 mL) and poured in aq. HCl (0.5M, 20 mL). The organic phase was separated 
and washed with aq. sat. NaHCO3 (2x 10 mL), dried and concentrated in vacuo, affording 7 (83.3 mg) 
as a colorless oil. [90% yield, 95% ee, [α]D = − 16.1 (c 2.7, CHCl3)]; 
1H-NMR δ 5.67 (ddd, J = 7.6, 
10.4 and 17.6Hz, 1H), 5.09-5.02 (m, 2H), 4.54 (bs, 1H), 3.20-3.09 (m, 1H), 2.95 (ddd, J = 5.4, 8.0 and 
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13.3Hz, 1H), 2.37-2.26 (m, 1H), 1.44 (s, 9H), 1.01 (d, J = 6.8Hz, 3H); 
13C-NMR δ 155.9, 141.3, 114.9, 
78.9, 45.6, 38.3, 28.3, 17.3; MS (EI) m/z 130 (6), 129 (17), 59 (19), 57 (100), 56 (7), 55 (11); MS (CI) 
m/z 204 (13), 203 ([M+NH4]+, 100), 202 (5), 187 (7), 186 ([M+H]+, 58), 163 (9), 148 (5), 147 (63), 
130 (33), 86 (7). HRMS Calcd. for [M-Me2C=CH2]
+ C6H11NO2 129.0790, found 129.0797. 
Enantiomeric excess determined by chiral GC analysis, CP-Chiralsil-Dex-CB (25 m x 0.25 mm), initial 
temp. 85 ºC, rate 10 °C/min., fin. temp. 120 °C, retention times (min): 61.4 (major) and 64.7 (minor). 
 
(+)-(R)-4-((tert-Butoxycarbonyl)(p-toluenesulfonyl)amino)- 
3-methylbutan-2-one (4b): 
The title compound was prepared in an analogous way to 4a from 2b. 
Purification by flash column chromatography (SiO2, 10:90 Et2O/pentane, Rf = 0.05) afforded 4b (145.3 
mg) as a colorless oil. [82% yield, 95% ee, [α]D = + 2.6 (c 7.1, CHCl3]; 
1H-NMR δ 7.77 (d, J = 8.2Hz, 
2H), 7.30 (d, J = 8.0Hz, 2H), 4.04 (dd, J = 6.0 and 14.6Hz, 1H), 3.90 (dd, J = 8.0 and 14.6Hz, 1H), 
3.16-3.02 (m, 1H), 2.43 (s, 3H), 2.21 (s, 3H), 1.31 (s, 9H), 1.21 (d, J = 7.2Hz, 3H); 
13C-NMR δ 210.1, 
150.8, 144.2, 136.9, 129.1, 127.7, 84.4, 48.5, 47.1, 28.6, 27.6, 21.4, 14.2; MS (EI) m/z 282 ([M-tBuO]
+, 
5), 200 (9), 198 (6), 191 (27), 184 (35), 156 (5), 155 (53), 144 (31), 120 (15), 108 (27), 102 (7), 100 
(27), 91 (50), 72 (10), 65 (11), 61 (9), 58 (20), 57 (100), 56 (6); MS (CI) m/z 375 (11), 374 (31), 373 
([M+NH4]+, 100), 317 (5), 219 (6), 69 (5). HRMS Calcd. for [M-tBuO]
+ C13H16NO4S 282.0800, found 
282.0805. Enantiomeric excess determined by chiral HPLC analysis, Chiralcel AD (98% heptane/i-
PrOH), 40ºC, retention times (min): 16.8 (major) and 20.9 (minor). 
 
 (−)-(R)-3-((tert-Butoxycarbonyl)(p-toluenesulfonyl)amino)- 
2-methylpropan-1-ol (5b): 
The title compound was prepared in an analogous way to 5a from 2b. 
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Purification by flash column chromatography (SiO2, 50:50 Et2O/pentane, Rf = 0.25) afforded 5b (132.8 
mg) as a colorless oil, which crystallized upon standing. [77% yield, 95% ee, [α]D = − 3.3 (c 8.1, 
CHCl3), mp = 59.8-60.4 °C]; 
1H-NMR δ 7.73 (d, J = 8.2Hz, 2H), 7.28 (d,  J = 8.5Hz, 2H), 3.85 (dd, J = 
9.1 and 14.6Hz, 1H), 3.72 (dd, J = 5.3 and 14.6Hz, 1H), 3.70-3.63 (m, 1H), 3.51-3.43 (m, 1H), 2.63 
(bs, 1H), 2.41 (s, 3H), 2.16-2.04 (m, 1H),m 1.29 (s, 9H), 1.00 (d, J = 7.0Hz, 3H); 
13C-NMR δ 151.9, 
144.3, 137.1, 129.2, 127.6, 84.8, 63.6, 49.1, 36.4, 27.7, 21.5, 14.5; MS (EI) m/z 270 ([M-tBuO]
+, 5), 
184 (47), 179 (28), 155 (48), 120 (14), 108 (26), 92 (8), 91 (52), 65 (12), 58 (6), 57 (100), 56 (6); MS 
(CI) m/z 363 (8), 362 (22), 361 ([M+NH4]
+, 100), 305 (11). HRMS Calcd. for [M-tBuO]
+ C12H16NO4S 
270.0800, found 270.0787. Enantiomeric excess determined by chiral HPLC analysis, Chiralcel AD 
(98% heptane/i-PrOH), 40ºC, retention times (min): 38.6 (major) and 51.0 (minor). 
 
(−)-3-((tert-Butoxycarbonyl)(p-toluenesulfonyl)amino)- 
2-ethylpropan-1-ol (5e):  
The title compound was prepared in an analogous way to 5a from 2e. 
Purification by flash column chromatography (SiO2, 50:50 Et2O/pentane, Rf = 0.25) afforded 5e (131.0 
mg) as a colorless oil. [74% yield, 90% ee, [α]D = − 6.8 (c 5.8, CHCl3 ]; 
1H-NMR δ  7.73 (d, J = 8.4Hz, 
2H), 7.29 (d, J = 8.6Hz, 2H), 3.87-3.74 (m, 2H), 3.73-3.56 (m, 2H), 2.69 (bs, 1H), 2.42 (s, 3H), 1.86-
1.77 (m, 1H), 1.56-1.44 (m, 1H), 1.43-1.32 (m, 1H), 1.30 (s, 9H), 0.99 (t, J = 7.5Hz, 3H); 
13C-NMR δ  
152.0, 144.3, 137.0, 129.2, 127.6, 85.0, 60.3, 48.0, 42.9, 27.7, 21.6, 21.5, 11.5; MS (EI) m/z 284 ([M-
tBuO]
+, 2), 216 (5), 193 (15), 184 (25), 155 (29), 120 (5), 108 (14), 92 (9), 91 (49), 65 (14), 57 (100), 
56 (8), 55 (7); MS (CI) m/z 377 (10), 376 (27), 375 ([M+NH4]
+, 100), 319 (47). HRMS Calcd. for [M-
tBuO]
+ C13H18NO4S 284.0956, found 284.0973. Enantiomeric excess determined by chiral HPLC 
analysis, Chiralcel AD (98% heptane/i-PrOH), 40ºC, retention times (min): 35.2 (major) and 52.7 
(minor). 
S
N
O
O
O
O
OH   S  14
(+)-(R)-3-(p-Toluenesulfonylamino)- 
1-(tert-butoxycarbonyloxy)-2-methylpropane (8): 
Ozone was bubbled for 10 min through a solution of 2b (0.5 mmol) in CH2Cl2/MeOH (1:1,15mL) 
cooled to -78°C. NaBH4 (2.5 eq., 2.5 mmol, 95 mg) was added at -78°C after which the cooling bath 
was removed and the reaction mixture was stirred at rt for 2 h.  The solvents were removed from the 
reaction mixture by rotavap (waterbath at 60 °C), followed by addition of aq. HCl (1M, 15 mL) and 
Et2O (25 mL). The organic layer was separated and the resulting aqueous layer extracted with Et2O (2x 
25 mL), the combined organic layers were dried (MgSO4) and concentrated in vacuo. Purification by 
flash column chromatography (SiO2, 30:70 Et2O/pentane, Rf = 0.30) afforded 8 (123.8 mg) as a 
colorless oil. [69% yield, 95% ee, [α]D = + 0.6 (c 7.9, CHCl3)]; 
1H-NMR δ  7.74 (d, J = 8.2Hz, 2H), 
7.29 (d, J = 8.2Hz, 2H), 5.22 (t, J = 6.6Hz, 1H), 4.00 (dd, J = 4.7 and 11.2Hz, 1H), 3.88 (dd, J = 6.7 
and 11.2Hz, 1H), 2.95-2.79 (m, 2H), 2.41 (s, 3H), 2.06-1.90 (m, 1H), 1.44 (s, 9H), 0.93 (d, J = 6.9Hz, 
3H); 
13C-NMR δ 153.6, 143.2, 136.9, 129.6, 126.9, 82.2, 68.8, 45.6, 33.2, 27.6, 21.4, 14.4; MS (EI) m/z 
226 (25), 225 (6), 224 (23), 199 (7), 197 (8), 188 (9), 185 (9), 184 (88), 157 (6), 156 (9), 155 (100), 
133 (8), 132 (25), 119 (6), 92 (12), 91 (80), 70 (73), 65 (17), 59 (6), 57 (71), 56 (12); MS (CI) m/z 363 
(7), 362 (19), 361 ([M+NH4]
+, 100), 333 (14), 305 (6), 289 (14). HRMS Calcd. for [M-tBuO]
+ 
C12H16NO4S 270.0800, found 270.0795. Enantiomeric excess determined by chiral HPLC analysis, 
Chiralcel AS-H (90% heptane/i-PrOH), 40ºC, retention times (min): 40.3 (minor) and 43.0 (major). 
 
(−)-(R)-3-((tert-Butoxycarbonyl)(p-toluenesulfonyl)amino)-2-
methylpropionic acid (6b): 
The title compound was prepared in an analogous way to 6a from 2b. The 
product 6b (140.9 mg) was obtained as a white crystalline solid. [79% yield, 95% ee, [α]D = − 9.5 (c 
3.6, CHCl3), mp = 114.4-116.3 °C]; 
1H-NMR δ 10.27 (bs, 1H), 7.80 (d, J = 8.4 Hz, 2H), 7.31 (d, J = 
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8.6 Hz, 2H), 4.14 (dd, J = 6.8 and 14.5 Hz, 1H), 3.96 (dd, J = 7.7 and 14.5 Hz, 1H), 3.10-3.01 (m, 1H), 
2.44 (s, 3H), 1.33 (s, 9H), 1.29 (d, J = 7.2 Hz, 3H);
 13C-NMR δ 180.5, 150.9, 144.3, 137.0, 129.2, 
127.9, 84.7, 48.7, 39.7, 27.7, 21.6, 14.5; MS (EI) m/z 284 ([M-tBuO]
+, 4), 194 (5), 193 (44), 185 (5), 
184 (54), 156 (5), 155 (55), 120 (18), 112 (7), 108 (34), 102 (11), 92 (7), 91 (57), 65 (14), 57 (100), 56 
(7); MS (CI) m/z 377 (8), 376 (19), 375 ([M+NH4]+, 100), 319 (16), 275 (6), 174 (7). HRMS Calcd. for 
[M-tBuO]
+ C12H14NO5S 284.0592, found 284.0607. Enantiomeric excess determined on derivatized 
product 9. 
 
 (−)-(R)-Methyl 3-((tert-butoxycarbonyl)(p-toluenesulfonyl)amino)-2-
methylpropionate (9): 
To a solution of 6b (0.19 mmol, 65 mg) and MeOH (1mL) in toluene (3mL), 
TMSCHN2 (1.0 mmol, 1.0M in Et2O, 0.5 mL) was added. The reaction mixture was stirred at rt for 1h, 
then MeOH (2mL) was added and the excess TMSCHN2 was destroyed through addition of AcOH (0.5 
mL). The mixture was diluted with toluene (5mL) and washed with sat. aq. NaHCO3 (5 mL, 2x). The 
organic layer was dried (MgSO4) and concentrated in vacuo to yield 9 (63.6 mg) as a colorless oil, 
which crystallised upon standing. [94% yield, 95% ee, [α]D = − 20.8  (c 2.8, CHCl3), mp = 75.8-78.6 
°C]; 
1H-NMR δ 7.77 (d, J = 8.2 Hz, 2H), 7.28 (d, J = 8.3 Hz, 2H), 4.08 (dd, J = 7.3 and 14.4 Hz, 1H), 
3.89 (dd, J = 7.2 and 14.4 Hz, 1H), 3.65 (s, 3H), 3.04-2.94 (m, 1H), 2.41 (s, 3H), 1.30 (s, 9H), 1.22 (d, 
J = 7.1 Hz, 3H); 
13C-NMR δ 174.6, 150.9, 144.2, 137.2, 129.2, 127.8, 84.4, 51.8, 49.1, 39.8, 27.7, 21.5, 
14.6; MS (EI) m/z 298 ([M-tBuO]
+, 4), 284 (12), 208 (7), 207 (56), 185 (6), 184 (56), 160, (7), 156 (5), 
155 (59), 120 (17), 116 (29), 112 (8), 108 (32), 92 (7), 91 (54), 88 (9), 84 (6), 65 (12), 57 (100), 56 (7); 
MS (CI) m/z 391 (7), 390 (20), 389 ([M+NH4]+, 100), 333 (13), 289 (6). HRMS Calcd. for [M-tBuO]
+ 
C13H16NO5S 298.0749, found 298.0733. Enantiomeric excess determined by chiral HPLC analysis, 
Chiralcel AD (99% heptane/i-PrOH), 40ºC, retention times (min): 26.9 (major) and 35.2 (minor). 
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(−)-(R)-Methyl 3-tert-butoxycarbonylamino-2-methyl-propionate (10):
14 
The title compound was prepared in an analogous way to 7 from 9 (0.104 
mmol, 38.8 mg). Work-up afforded compound 10 (20.5 mg) as a colorless oil. [90% yield, 95% ee, 
[α]D = − 21.8 (c 1.9, CHCl3); lit.
14 [α]D = − 17.6 (c 2.74, CHCl3)]; 
1H-NMR 4.94 (bs, 1H), 3.68 (s, 3H), 
3.35-3.19 (m, 2H), 2.72-2.61 (m, 1H), 1.41 (s, 9H), 1.15 (d, J = 7.2 Hz, 3H); 
13C-NMR δ 175.8, 155.9, 
79.3, 51.8, 42.9, 39.9, 28.3, 14.7; MS (EI) m/z 217 (M+, 1), 161 (29), 160 (8), 144 (19), 130 (30), 116 
(6), 112 (20), 101 (7), 88 (24), 84 (8), 59 (17), 58 (6), 57 (100), 56 (8); MS (CI) m/z 452 ([2M+NH4]+, 
10), 236 (12), 235 ([M+NH4]+, 100), 219 (6), 218 ([M+H]+, 45), 179 (16), 162 (11), 69 (9); HRMS 
Calcd. for C10H19NO4 217.1314, found 217.1327. Enantiomeric excess determined by chiral GC 
analysis, CP-Chiralsil-Dex-CB (25 m x 0.25 mm), isothermic 130 ºC, retention times (min): 13.3 
(major) and 14.6 (minor). 
 
 
Scheme S1: Derivatizations to establish ee of product 2c 
Reagents and conditions: i) 1. O3, DCM/MeOH, -78°C, 2. NaBH4 (5 
eq.), rt, 77%; ii) BnOC(NH)CCl3, TfOH, cyclohexane, CCl4, rt, 25%; 
iii) TBAF, THF, rt. 
 
                                                 
14 Ghosh, A. K.; Bischoff, A. Eur. J. Org. Chem. 2004, 2131. 
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(−)-(S)-3-(tert-Butyl-diphenyl-silanyloxy)-2-methylpropan-1-ol (5c):
15 
The title compound was prepared in an analogous way to 5a from 2c (0.29 
mmol, 93.1 mg). Purification by flash column chromatography (SiO2, 15:85 
Et2O/pentane, Rf = 0.20) afforded 5c (73.0 mg) as a colorless oil. [77% yield, 94% ee, [α]D = − 6.0 (c 
1.5, CHCl3); lit.
15 [α]D = − 5.3 (c 3.3, CHCl3)]; 
1H-NMR δ  7.71 (dd, J = 1.6 and 7.8Hz, 4H), 7.49-7.39 
(m, 6H), 3.77-3.59 (m, 4H), 2.68 (bs, 1H), 2.07-1.96 (m, 1H), 1.09 (s, 9H), 0.86 (d, J = 6.9Hz, 
3H); 
13C-NMR δ 135.5, 135.5, 133.1, 133.1, 129.7, 127.7, 68.6, 67.5, 37.3, 26.8, 19.1, 13.1; MS (EI) 
m/z 272 (7), 271 ([M-tBu]+, 30), 229 (8), 201 (5), 200 (19), 199 (100), 197 (7), 193 (18), 181 (9), 139 
(20), 77 (7); MS (CI) m/z 348 (8), 347 (28), 346 ([M+NH4]+, 100), 330 (13), 329 ([M+H]+, 47), 69 
(14). HRMS Calcd. for [M-tBu]
+ C16H19O2Si 271.1154, found 271.1149. Enantiomeric excess 
determined on derivatized product 5a. 
 
 (S)-1-Benzyloxy-3-(tert-butyl-diphenyl-silanyloxy)-2-
methylpropane (11): 
To a solution of 5c (0.15 mmol, 49.8 mg), benzyltrichloroacetimidate 
(0.3 mmol, 56 μL) and cyclohexane (0.3 mmol, 33 μL) in CCl4 (1 mL) a catalytic amount of TfOH (2 
μL) was added. The mixture was stirred at rt for 2.5h and quenched with 1 mL sat. aq. NaHCO3, after 
which 10 mL Et2O was added and the resulting solution washed with 10 mL H2O and 10 mL sat. aq. 
NaCl. The organic layer was dried with MgSO4 and concentrated in vacuo. Purification by flash 
column chromatography (SiO2, 1:99 Et2O/pentane, Rf = 0.20) afforded an inseparable mixture of 11 
and the byproduct dibenzylether
16 (32.4 mg) as a colorless oil. [11:Bn2O = 4:3, 25% calc. yield of 11, 
94% ee]; 
1H-NMR δ 7.69-7.64 (m, 4H), 7.45-7.26 (m, 11H + Bn2O, 10H), 4.58 (Bn2O, s, 4H), 4.50 (s, 
                                                 
15 P. R. Blakemore, C. C. Browder, J. Hong, C. M. Lincoln, P. A. Nagornyy, L. A. Robarge, D. J. Wardrop, J. D. White 
J. Org. Chem. 2005, 70, 5449. 
16 The identity of the byproduct was established through comparison of 
1H-NMR, 
13C-NMR and GCMS-data with a 
commercial sample. The characterisation of 10 was performed with the mixture of compounds. 
Si
O O
Si
O OH   S  18
2H), 3.68-3.61 (m, 2H), 3.56 (dd, J = 6.4 and 9.0 Hz, 1H), 3.40 (dd, J = 6.1 and 9.0 Hz, 1H), 2.09-1.97 
(m, 1H), 1.06 (s, 9H), 0.99 (d, J = 6.9 Hz, 3H);
13C-NMR δ 138.8, 138.3 (Bn2O), 135.6, 133.9, 129.5, 
128.4 (Bn2O), 128.3, 127.8 (Bn2O), 127.6 (Bn2O), 127.6, 127.5, 127.3, 73.0, 72.5, 72.1 (Bn2O), 65.7, 
36.3, 26.9, 19.3, 14.1; MS (EI) m/z 199 (8), 195 (7), 194 (18), 193 ([M - Ph, tBu, Bn]+, 100), 181 (6), 
91 (50); MS (CI) m/z 438 (13), 437 (35), 436 ([M+NH4]
+, 100), 419 ([M+H]
+, 14). HRMS Calcd. for 
[M - Ph, tBu, Bn]
+ C10H13O2Si 193.0685, found 193.0676. Enantiomeric excess determined of 
derivatized product 5a. To the mixture of 11 and dibenzylether (approx. 37 μmol 11, 21mg) 4 
equivalents of TBAF (0.15 mmol, 1.0M in THF, 0.15mL) were added at room temperature. After 
stirring for 2.5h, the reaction mixture was diluted with Et2O/pentane (1:1, 1mL) and the resulting 
mixture was flushed over a MgSO4 and SiO2 plug. The solution was concentrated providing the 
mixture of 5a and Bn2O as an oil. The enantiomeric excess of 5a was determined to be 94% by chiral 
HPLC analysis, Chiralcel AS (98.5% heptane/i-PrOH), 40ºC, retention times (min): 4.7 (Bn2O), 11.8 
(major) and 14.1 (minor).   S  19
1H NMR and 
13C-NMR: 
(−)-(S)-((2-Methylbut-3-enyloxy)methyl)benzene (2a): 
 
    S  20
(−)-(S)-(N-2-Methylbut-3-enyl)(N-t-butoxycarbonyl)-p-toluenesulfonamide (2b): 
 
    S  21
(−)-(S)-4-[(tert-Butyldiphenylsilyl)oxy]-3-methylbut-1-ene (2c): 
 
    S  22
(−)-(N-2-Ethylbut-3-enyl)(N-tert-butoxycarbonyl)-p-toluenesulfonamide (2e): 
 
    S  23
(+)-(S)-((2-n-Butylbut-3-enyloxy)methyl)benzene (2f): 
 
    S  24
(+)-(S)-((2-n-Pentylbut-3-enyloxy)methyl)benzene (2g): 
 
    S  25
(+)-(S)-(2-Vinyl-hex-5-enyloxymethyl)-benzene (2h): 
 
    S  26
(+)-(2-Vinyl-4-phenyl-butyloxymethyl)-benzene (2i): 
 
    S  27
(+)-(S)-4-Benzyloxy-3-methylbutan-1-ol (3): 
 
    S  28
(−)-(R)-4-Benzyloxy-3-methylbutan-2-one (4a): 
 
    S  29
(−)-(S)-3-Benzyloxy-2-methylpropan-1-ol (5a): 
 
    S  30
(−)-(R)-3-Benzyloxy-2-methylpropionic acid (6a): 
 
    S  31
(−)-(S)-(N-tert-Butoxycarbonyl)( 2-methylbut-3-enyl)amine (7): 
 
    S  32
(+)-(R)-4-((tert-Butoxycarbonyl)(p-toluenesulfonyl)amino)-3-methylbutan-2-one (4b): 
 
    S  33
(−)-(R)-3-((tert-Butoxycarbonyl)(p-toluenesulfonyl)amino)-2-methylpropan-1-ol (5b): 
 
    S  34
(−)-3-((tert-Butoxycarbonyl)(p-toluenesulfonyl)amino)-2-ethylpropan-1-ol (5e): 
 
    S  35
(+)-(R)-3-(p-Toluenesulfonylamino)-1-(tert-butoxycarbonyloxy)-2-methylpropane (8): 
 
    S  36
 (−)-(R)-3-((tert-Butoxycarbonyl)(p-toluenesulfonyl)amino)-2-methylpropionic acid (6b): 
 
    S  37
(−)-(R)-Methyl 3-((tert-butoxycarbonyl)(p-toluenesulfonyl)amino)-2-methylpropionate (9): 
 
    S  38
(−)-(R)-Methyl 3-tert-butoxycarbonylamino-2-methyl-propionate (10): 
 
    S  39
(−)-(S)-3-(tert-Butyl-diphenyl-silanyloxy)-2-methylpropan-1-ol (5c): 
 
    S  40
(S)-1-Benzyloxy-3-(tert-butyl-diphenyl-silanyloxy)-2-methylpropane (11): 
 
 